Region: South Africa

IP experts remain positive in the face of changes to the global life sciences landscape

AI, counterfeits and legislative overhauls are changing the game but contributors to the IAM Guide to Life Sciences offer strategic steps to help companies stay one step ahead

24 June 2024

South Africa: Winning strategies to keep pace with evolving pharma sector

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

The South African pharmaceutical industry has grown substantially in recent years, while patent legislation has undergone significant divergence. Effective enforcement, prosecution and launch-to-market strategies require a keen understanding of the country’s IP and regulatory frameworks.

24 June 2024

mRNA trade secrets to become even more important, says WHO vaccine hub boss

IAM talked with Petro Terblanche, CEO of Afrigen Biologics, about the WHO vaccine hub and its IP strategy

21 February 2024

Breakthrough in TRIPS covid waiver negotiations – here’s what you need to know

There are reports of a compromise deal agreeed by the US, EU, India and South Africa, but no official confirmation

16 March 2022

Lack of mRNA tech transfer “a blessing in disguise” for WHO vaccine team, says Afrigen boss

Petro Terblanche tells IAM about the IP issues surrounding her team’s new replica of Moderna’s covid-19 vaccine

10 February 2022

Talks over covid vaccine IP waiver appear increasingly futile

Saturday Opinion: The prospect of an international agreement on the proposed suspension of TRIPS now appears vanishingly small

23 October 2021

South Africa awards world’s first AI-invented patent, but it may not be that big a deal

The country's IP office does not subject applications to substantive examination meaning grants are virtually guaranteed if formalities are complied with

28 July 2021

All the big legal, market and deals news from the life sciences sector in June

In June’s round-up of life sciences-related news, we report on the US Supreme Court’s decision to grant certiorari in the Helsinn Healthcare v Teva Pharmaceuticals Section 102 dispute, but not in the Cleveland Clinic’s Section 101 case against True…

07 July 2018

South Africa moves to substantive examination for pharma patents, amid fears system could grind to halt

New IP policy looks to get tough on evergreening in pharma industry but also brings country closer to international best practices.

15 June 2018

Criticism grows over World Cup prohibited marks

Controversy has surrounded the publication of a list of FIFA trademarks and words, which the minister of trade and industry proposes be declared as prohibited marks in preparation for the 2010 World Cup. Critics argue that none of these marks is unique to FIFA and the list could potentially lead to absurdities, such as making any 2010 calendar illegal.

10 October 2007